|
Solutions > Vascular Solutions
VASCULAR SOLUTIONS
Critical Limb Ischemia
Chronic critical limb ischemia (CLI) is the end result of the arterial occlusive disease, and the most common form is atherosclerosis. Aggressive endovascular therapy with angioplasty/stenting and open surgical approaches with distal vein grafting has reduced the amputation rates in many communities. However, some patients exhaust these options and face amputation if nothing more can be done to improve peripheral perfusion. Bone marrow derived stem cells can induce neovascularization and improve angiogenesis in ischemic areas and enable limb salvage. Autologous bone marrow therapy for CLI appears to be a promising solution to the current lack of treatments in patients ineligible for endovascular or surgical interventions. Bone marrow normally provides progenitor CD-34 cells that can migrate to ischemic tissue to form new blood vessels. These progenitor cells adhere to ischemic endothelium and then migrate into the local environ to cause vasculogenesis.
“Angiogenesis induced by autologous bone marrow transplantation is a feasible, secure and with
Harvest Tech separation, also a simple therapy. Preliminary results, autologous BMT in CLI can help avoid amputations.”
Amann: International Symposium on Peri-Operative Blood Management, Oct 2007
References - Vascular
Hamano, K, et al, The Induction of Angiogenesis by the Implantation of Autologous Bone Marrow Cells: A Novel and Simple Therapeutic Method, Surgery, 2001; 130:44-54.
Yuyama, E, et al, Therapeutic Angiogenesis for Patients with Limb Ischemia by Autologous Transplantation of Bone-Marrow Cells: A Pilot Study and a Randomised Controlled Trial, The Lancet, 2002; 360:427-435
Esato, K, et al, Neovascularization Induced by Autlogous Bone Marrow Cell Implantation in Peripheral Arterial Disease, Cell Transplantation, 2002; 11:747-752
Al-Khaldi, A, et al, Therapeutic Angiogenesis Using Autlogous Bone Marrow Stromal Cells: Improved Blood Flow in a Chronic Limb Ischemia Model, Annuals of Thoracic Surgery, 2003; 75:204-209
Saigawa, T, et al, Clinical Application of Bone Marrow Implantation in Patients with Arteriosclerosis Obliterans, and the Association between Efficacy and the Number of Implanted Bone Marrow Cells, Circulation Journal, 2004; 68:1189-1193
Amann, B, et al, Bone Marrow Stem Cell Injections: Can They be a Treatment for Critical Ischemia and How do They Work?, Vascular, 2006; 14:S153
Saratzis, N, et al, Non-Activated Autologous Platelet-Rich Plasma for the Prevention of Inguinal Wound-Related Complications After Endovascular Repair of Abdominal Aortic Aneurysms, Journal of ExtraCorporeal Technology, 2008; 40:52-56
Carter, C, et al, Platelet-Rich Plasma Gel Promotes Differentiation and Regeneration During Equine Wound Healing, Experimental and Molecular Pathology, 2003; 74:244-245
Glover, J., et al, A 4-Year Outcome-Based Retrospective Study of Wound Healing and Limb Salvage in Patients with Chronic Wounds, Advanced Wound Care, 1997, 10:33-38
Barett, S, A New Approach to Using Growth Factors in Wound Healing, Podiatry Today, 2003, 16:44-50
Friese, G, et al, Activated Autologous Platelet Concentrate (APC+): The New Perspective in Treatment of Chronic Diabetic Foot Ulcers, 2nd World Union of Wound Healing Podium Presentation, July, 2004
Crovetti, G, et al, Platelet Gel for Healing Cutaneous Chronic Wounds, Transfusion and Apheresis Science, 2004; 30:145-151
Saldalamacchia, G, et al, A Controlled Study of the Use of Autologous Platelet Gel for the Treatment of Diabetic Foot Ulcers, Nutr Metab Cardiovasc Dis, 2004; 14:395-396
Knox, R, et al, Platelet-Rich Plasma Combined with Skin Substitute for Chronic Wound Healing: A Case Report, Journal of Extracorporeal Technology, 2006; 38:260-264
Friese, G, et al, The Use of Autologous Platelet Concentrate Activated by Autologous Thrombin is Effective and Safe in the Treatment of Chronic Diabetic Foot Ulcers – A Randomized Controlled Study, The 5th International Symposium on the Diabetic Foot Podium Presentation, 2007, May 11
Hom, D, et al, The Healing Effects of Autologous Platelet Gel on Acute Human Skin Wounds, Archives of Facial Plastic Surgery, 2007; 9:174-183
Barrett, S, Use of Autologous Platelet Grafting in the Treatment of a Diabetic Ulceration Sub 1st Metatarsalphalangeal Joint - Case Review
Barrett, S, Use of Autologous Platelet Grafting in the Treatment of a Diabetic Ulceration and Chronic Surgical Wound - Case Review
Barrett, S, Use of Autologous Platelet Grafting in the Treatment of a Chronic Wound Dehiscence - Case Review |
|
Dr. A.P.J. Abdul Kalam has inaugurated TRICell - Stem Cell Center on 28th November 2007, Wednesday at 4:00pm |
|